These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38345119)
1. The place of selective serotonin reuptake inhibitors (SSRIs) in the treatment of depressive disorders in children and adolescents. Recommendations of the Main Board of the Polish Psychiatric Association. Part 2 - pharmacological properties and safety of use. Janas-Kozik MH; Słopień A; Remberk B; Siwek M Psychiatr Pol; 2023 Oct; 57(5):917-940. PubMed ID: 38345119 [TBL] [Abstract][Full Text] [Related]
2. The place of selective serotonin reuptake inhibitors (SSRIs) in the treatment of depressive disorders in children and adolescents. Recommendations of the Main Board of the Polish Psychiatric Association. Part 1 - Clinical efficacy and areas of application. Janas-Kozik MH; Słopień A; Remberk B; Siwek M Psychiatr Pol; 2023 Oct; 57(5):899-916. PubMed ID: 38345118 [TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776 [TBL] [Abstract][Full Text] [Related]
4. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents]. Bailly D Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [TBL] [Abstract][Full Text] [Related]
6. Antidepressants for people with epilepsy and depression. Maguire MJ; Marson AG; Nevitt SJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531 [TBL] [Abstract][Full Text] [Related]
8. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)]. Hjalmarsson L; Corcos M; Jeammet P Encephale; 2005; 31(3):309-16. PubMed ID: 16142045 [TBL] [Abstract][Full Text] [Related]
9. Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful? Shelton CI J Clin Psychiatry; 2004; 65 Suppl 17():29-33. PubMed ID: 15600379 [TBL] [Abstract][Full Text] [Related]
10. Use of selective serotonin reuptake inhibitors in children and adolescents. Wong IC; Besag FM; Santosh PJ; Murray ML Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506 [TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition. Westin AA; Brekke M; Molden E; Skogvoll E; Spigset O PLoS One; 2017; 12(7):e0181082. PubMed ID: 28708853 [TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults. Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents]. Bailly D Presse Med; 2006 Sep; 35(9 Pt 2):1293-302. PubMed ID: 16969324 [TBL] [Abstract][Full Text] [Related]
14. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children]. Tandt H; Audenaert K; van Heeringen C Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368 [TBL] [Abstract][Full Text] [Related]
15. Antidepressants for people with epilepsy and depression. Maguire MJ; Weston J; Singh J; Marson AG Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of selective serotonin reuptake inhibitors in the treatment of depression in children and adolescents: practitioner review. Sharp SC; Hellings JA Clin Drug Investig; 2006; 26(5):247-55. PubMed ID: 17163258 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Stahl SM; Entsuah R; Rudolph RL Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062 [TBL] [Abstract][Full Text] [Related]
18. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525 [TBL] [Abstract][Full Text] [Related]
19. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo. Mallick R; Chen J; Entsuah AR; Schatzberg AF J Clin Psychiatry; 2003 Mar; 64(3):321-30. PubMed ID: 12716275 [TBL] [Abstract][Full Text] [Related]
20. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder. Khandker RK; Kruzikas DT; McLaughlin TP J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]